Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZMO -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (249)	3/23/2000 4:08:00 PM
From: jeffbas	Respond to of 438

Precisely. This offering is designed to do just that AND to give the company serious Wall Street coverage and institutional exposure. NB: If this was not their objective, they could have just exercised their $30 million equity line of credit with Genzyme at probably a higher price (because it is based on a lagging moving average).

To: Mike McFarland who wrote (249)	3/23/2000 4:48:00 PM
From: rkrw	Read Replies (1) \| Respond to of 438

With the buyback option in place there's only so far GZMO can remove itself from GENZ. Two real steps would be eliminate the buyback option then change its name :-)